Hutchison China MediTech Ltd ADR Stock
The Hutchison China MediTech Ltd ADR stock is trending slightly upwards today, with an increase of €0.10 (0.810%) compared to yesterday's price.
Currently there is a rather positive sentiment for Hutchison China MediTech Ltd ADR with 3 Buy predictions and 1 Sell predictions.
As a result the target price of 17 € shows a positive potential of 36.0% compared to the current price of 12.5 € for Hutchison China MediTech Ltd ADR.
Pros and Cons of Hutchison China MediTech Ltd ADR in the next few years
Pros
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Hutchison China MediTech Ltd ADR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Hutchison China MediTech Ltd ADR | 0.810% | 11.607% | 9.649% | -14.966% | 14.679% | -21.875% | -57.192% |
| China Traditional Chinese Medicine Co Ltd | 0.890% | 1.818% | -1.754% | -11.111% | 2.752% | -51.304% | -41.053% |
| China Resources Pharmaceutical Group Ltd | - | 3.347% | 1.230% | -22.813% | 3.782% | -28.406% | 21.675% |
| Repligen Corp. | -1.500% | 2.318% | 4.138% | -3.336% | 1.846% | -12.955% | -15.369% |
Comments
HUTCHMED (NASDAQ:HCM) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (NASDAQ:HCM) was downgraded by analysts at Morgan Stanley from an "equal weight" rating to an "underweight" rating. They now have a $13.75 price target on the stock.
Show more
Ratings data for HCM provided by MarketBeat
HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) had its price target raised by analysts at Bank of America Corporation from $27.00 to $28.00. They now have a "buy" rating on the stock.
Show more
Ratings data for HCM provided by MarketBeat